Medical & General Independent Financial Advisers Ltd 08970384 false 2024-05-01 2025-04-30 2025-04-30 The principal activity of the company is provision of independent financial advice. Digita Accounts Production Advanced 6.30.9574.0 true 08970384 2024-05-01 2025-04-30 08970384 2025-04-30 08970384 bus:Director2 1 2025-04-30 08970384 bus:OrdinaryShareClass1 bus:CumulativeShares 2025-04-30 08970384 core:CurrentFinancialInstruments 2025-04-30 08970384 core:CurrentFinancialInstruments core:WithinOneYear 2025-04-30 08970384 core:Non-currentFinancialInstruments core:AfterOneYear 2025-04-30 08970384 core:FurnitureFittingsToolsEquipment 2025-04-30 08970384 bus:SmallEntities 2024-05-01 2025-04-30 08970384 bus:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 08970384 bus:FilletedAccounts 2024-05-01 2025-04-30 08970384 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 08970384 bus:RegisteredOffice 2024-05-01 2025-04-30 08970384 bus:CompanySecretary1 2024-05-01 2025-04-30 08970384 bus:Director2 2024-05-01 2025-04-30 08970384 bus:Director2 1 2024-05-01 2025-04-30 08970384 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-05-01 2025-04-30 08970384 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 08970384 bus:Agent1 2024-05-01 2025-04-30 08970384 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-05-01 2025-04-30 08970384 core:IntangibleAssetsOtherThanGoodwill 2024-05-01 2025-04-30 08970384 core:ComputerEquipment 2024-05-01 2025-04-30 08970384 core:FurnitureFittings 2024-05-01 2025-04-30 08970384 core:FurnitureFittingsToolsEquipment 2024-05-01 2025-04-30 08970384 core:OtherRelatedParties 2024-05-01 2025-04-30 08970384 countries:UnitedKingdom 2024-05-01 2025-04-30 08970384 2024-04-30 08970384 bus:Director2 1 2024-04-30 08970384 core:FurnitureFittingsToolsEquipment 2024-04-30 08970384 2023-05-01 2024-04-30 08970384 2024-04-30 08970384 bus:Director2 1 2024-04-30 08970384 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-04-30 08970384 core:CurrentFinancialInstruments 2024-04-30 08970384 core:CurrentFinancialInstruments core:WithinOneYear 2024-04-30 08970384 core:Non-currentFinancialInstruments core:AfterOneYear 2024-04-30 08970384 core:FurnitureFittingsToolsEquipment 2024-04-30 08970384 bus:Director2 1 2023-05-01 2024-04-30 08970384 bus:Director2 1 2023-04-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 08970384

Medical & General Independent Financial Advisers Ltd

Unaudited Filleted Abridged Financial Statements

for the Year Ended 30 April 2025

 

Medical & General Independent Financial Advisers Ltd

Contents

Company Information

1

Abridged Balance Sheet

2 to 3

Notes to the Unaudited Abridged Financial Statements

4 to 9

 

Medical & General Independent Financial Advisers Ltd

Company Information

Director

Mr M D Harms

Company secretary

Mrs H E Harms

Registered office

Mey House
Bridport Road
Poundbury
Dorset
DT1 3QY

Accountants

Spirare Limited
Chartered Certified AccountantsMey House
Bridport Road
Poundbury
Dorset
DT1 3QY

 

Medical & General Independent Financial Advisers Ltd

(Registration number: 08970384)
Abridged Balance Sheet as at 30 April 2025

Note

2025
£

2024
£

Fixed assets

 

Intangible assets

4

40,307

52,096

Tangible assets

5

41,819

40,956

 

82,126

93,052

Current assets

 

Debtors

288,140

217,635

Cash at bank and in hand

 

145,663

123,304

 

433,803

340,939

Prepayments and accrued income

 

1,509

-

Creditors: Amounts falling due within one year

(181,752)

(108,890)

Net current assets

 

253,560

232,049

Total assets less current liabilities

 

335,686

325,101

Creditors: Amounts falling due after more than one year

(1,151)

(11,629)

Provisions for liabilities

(10,911)

(13,393)

Accruals and deferred income

 

(10,672)

(5,503)

Net assets

 

312,952

294,576

Capital and reserves

 

Called up share capital

6

4

4

Retained earnings

312,948

294,572

Shareholders' funds

 

312,952

294,576

For the financial year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

For the financial year ending 30 April 2025 the company was entitled to exemption from audit under section 479A of the Companies Act 2006 relating to subsidiary companies.

For the financial year ending 30 April 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

 

Medical & General Independent Financial Advisers Ltd

(Registration number: 08970384)
Abridged Balance Sheet as at 30 April 2025

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 10 June 2025
 

.........................................
Mr M D Harms
Director

 

Medical & General Independent Financial Advisers Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
Mey House
Bridport Road
Poundbury
Dorset
DT1 3QY

These financial statements were authorised for issue by the director on 10 June 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Medical & General Independent Financial Advisers Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office furniture and fittings

15% reducing balance

Computer equipment

33.3% reducing balance

Amortisation

Asset class

Amortisation method and rate

Other intangible asset

25% reducing balance

Internally generated software development

5 year straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

 

Medical & General Independent Financial Advisers Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 14 (2024 - 11).

 

Medical & General Independent Financial Advisers Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

4

Intangible assets

Total
£

Cost or valuation

At 1 May 2024

63,020

Additions acquired separately

358

At 30 April 2025

63,378

Amortisation

At 1 May 2024

10,924

Amortisation charge

12,147

At 30 April 2025

23,071

Carrying amount

At 30 April 2025

40,307

At 30 April 2024

52,096

5

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 May 2024

111,407

111,407

Additions

13,289

13,289

At 30 April 2025

124,696

124,696

Depreciation

At 1 May 2024

70,451

70,451

Charge for the year

12,426

12,426

At 30 April 2025

82,877

82,877

Carrying amount

At 30 April 2025

41,819

41,819

At 30 April 2024

40,956

40,956

6

Share capital

Allotted, called up and fully paid shares

 

Medical & General Independent Financial Advisers Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

2025

2024

No.

£

No.

£

Ordinary of £1 each

4

4

4

4

       

7

Related party transactions

Transactions with the director

2025

At 1 May 2024
£

Advances to director
£

Repayments by director
£

At 30 April 2025
£

Mr M D Harms

The director maintains an interest free loan account which is repayable on demand

(77)

(261)

725

387

2024

At 1 May 2023
£

Advances to director
£

Repayments by director
£

At 30 April 2024
£

Mr M D Harms

The director maintains an interest free loan account which is repayable on demand

(2,590)

(642)

3,155

(77)

Director's remuneration

The director's remuneration for the year was as follows:

2025
£

2024
£

Contributions paid to money purchase schemes

6,000

4,500

Summary of transactions with other related parties

 

Medical & General Independent Financial Advisers Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025


Medical & General Independent Fiancial Advisers Ltd received financial services from MDH Wealth Management Ltd.

The total expense amounted to £191,035 (2024 - £243,624). Transactions were carried out on commercial terms.

The amount due to MDH Wealth Management Ltd from Medical & General Independent Financial Advisors Ltd at the year end was £21,305 (2024 - £39,657). This is disclosed in trade creditors.

Mr M Harms, director, controls Medical & General Independent Financial Advisers Ltd and MDH Wealth Management Ltd.

Medical & General Independent Financial Advisers Ltd loaned funds to Greenways Wealth Management totalling £225 (2024 - £25,775). This is disclosed in other debtors. The amount due to Medical & General Independent Financial Advisers Ltd from Greenways Wealth Management Ltd at the year end was £26,000 (2024 - £25,775). Greenways Wealth Management Ltd owns 100% of the issued share capital in Medical & General Independent Financial Advisers Ltd.

Greenways Wealth Management Ltd owns 100% of the issued share capital in John Mitchell Financial Advisers Ltd, and Mr M Harms, director, controls Greenways Wealth Management Ltd.

Medical & General Independent Financial Advisers Ltd loaned funds to John Mitchell Financial Advisers totalling £225 (2024 - £nil). This is disclosed in other debtors. The amount due to Medical & General Independent Financial Advisers Ltd from John Mitchell Financial Advisors Ltd at the year end was £225 (2024 - £nil).